References
- White DJ, Calne RY. The use of cyclosporin A. Immunosuppression in organ grafting. Immunol Rev 1982; 65: 115–31
- Shevach EM. The effect of cyclosporin A on the immune system. Ann Rev Immunol 1985; 3: 397–423
- Hess AD, Colombani PM, Esa AH. Cyclosporine and the immune response: basic aspects. Crit Rev Immunol 1986; 6: 123
- Tutschka PJ, Beschorner WE, Allison AC, Burns WH, Santos GW. Use of Cyclosporine A in allogeneic bone marrow transplantation in the rat. Nature 1979; 280: 5718–9
- Bacigalupo A, Maiolino A, Van Lint MT, Occhini D, Gualandi F, Clavio M. Cyclosporin A and chronic graft versus host disease. Bone Marrow Transplant 1990; 6: 341–4
- Stiller CR, Dupre J, Gent R, Jenner MR, Keown PA. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 1984; 223: 1362–7
- Bolton C, Allsopp G, Cuzner ML. The effect of cyclosporin A on the adoptive-transfer of experimental allergic encephalomyelitis in the Lewis rat. Clin Exp Immunol 1982; 47: 127–32
- Von Graffenried B, Friend D, Shand N, Schiess W, Timonen P. Cyclosporin A (SandimmunR) in autoimmune disorders. Cyclosporin Mode of action and clinical applications, AW. Thomson. Kluwer Academic, London 1989; 213–50
- Glazier A, Tutschka PJ, Farmer ER, Santos GW. Graft-versus-host disease in Cyclosporin A-treated rats after syngeneic and autologous bone marrow transplantation. J Exp Med 1983; 158: 1–8
- Sorokin R, Kimura H, Schroder K, Wilson DH, Wilson DB. Cyclosporin-induced autoimmunity. Conditions for expressing disease. Requirement for intact thymus, and potency estimates of autoimmune lymphocytes in drug-treated rats. J Exp Med 1986; 164: 1615–25
- Bos GMJ, Majoor GD, Van Breda Vriesman PJC. Graft-versus-host disease: the need for a new terminology. Immunol Today 1990; 11: 433–6
- Cheney RT, Sprent J. Capacity of Cyclosporine to induce auto-graft-versus-host disease and impair intrathymic T cell differentiation. Transplant Proc 1985; 17: 528–30
- Bryson JS, Jennings CD, Caywood BE, Kaplan AM. Induction of a syngeneic graft-versus-host disease-like syndrome in DBA/2 mice. Transplantation 1989; 48: 1042–7
- Jones RJ, Hess AD, Mann RB, Piantadosi S, Vogelsang GB, Farmer ER, Geller RB, Santos GW. Induction of graft-versus-host disease after autologous bone marrow transplantation. Lancet 1989; 1: 754–7
- Fischer AC, Hess AD. Age-related factors in Cyclosporin-induced syngeneic graft-versus-host disease: regulatory role of marrow-derived T lymphocytes. J Exp Med 1990; 172: 85–94
- Tutschka PJ, Berkowitz SD, Tuttle S, Klein J. Graft-versus-leukemia in the rat: The antileukemic efficacy of syngeneic and allogeneic graft-versus-host disease. Transplant Proc 1987; 19: 2668–73
- Geller RB, Esa AH, Beschorner WE, Frondoza CG, Santos GW, Hess AD. Successful in vitro graft-versus-tumor effect against an la-bearing tumor using cyclosporin induced syngeneic graft-versus-host disease in the rat. Blood 1989; 74: 1165–71
- Bos GMJ, Majoor GD, Van Breda Vriesman PJC. Cyclosporin A induces a selective, reversible suppression of T-helper lymphocyte regeneration after syngeneic bone marrow transplantation: association with syngeneic graft-versus-host disease in rats. Clin Exp Immunol 1988; 74: 443–8
- Wodzig KWH, Majoor GD, Van Breda Vriesman PJC. On the localization of effector cells in cyclosporin-induced autoimmunity. Autoimmunity 1991; 10: 275–83
- Thorbecke GJ, Silberberg-Sinakin I, Flotte TJ. Langerhans cells as macrophages in skin and lymphoid organs. J Invest Dermatol 1980; 75: 32–43
- Wijsbek AM, Majoor GD, Slaaf DW, Bos GMJ, Meijers-Jellema R, Weijmer-van Velzen JS, Van Breda Vriesman PJC. Detection of contact dermatitis in rat skin by intravital microscopy. Int J Microcirc Clin Exp 1991; 10: 193–204
- Herberman RB. Natural killer cells and their possible relevance to transplantation biology. Transplantation 1982; 34: 1–7
- Steinbrüchel DA, Koch C, Kristensen T, Kemp E. Monoclonal antibody treatment (anti-CD4 and anti-Interleukin-2 receptor) combined with Cyclosporin A has a positive but not simple dose-dependent effect on rat renal allograft survival. Scand J Immunol 1991; 34: 627–33
- Brüning JH, Bruggeman CA, Van Breda Vriesman PJC. The effect of cytomegalovirus infection on renal allograft function and rejection in a rat model. Transplantation 1989; 47: 742–4
- Beschorner WE, Namnoun JD, Hess AD, Shinn CA, Santos GW. Cyclosporin A and the thymus. Immunopathology. Am J Pathol 1987; 126: 487
- Beschorner WE, Armas OA. Loss of medullary dendritic cells in the thymus after cyclosporine and irradiation. Cell Immunol 1991; 132: 505
- Schuurman H-J, Van Loveren H, Rozing J, Van Dijk A, Loeber JG, Vos JG. Cyclosporin and the rat thymus. An immunohistochemical study. Thymus 1990; 16: 235–54
- Fischer AC, Laulis MK, Horwitz L, Hess AD. Effect of Cyclosporine on T lymphocyte development. Relationship to syngeneic graft-versus-host disease. Transplantation 1991; 51: 252–9
- Bos GMJ, Majoor GD, Van de Gaar M-J, Van Breda Vriesman PJC. T-helper lymphocytes and syngeneic graft-versus-host disease. Transplant Proc 1989; 21: 3016–7
- Fowell D, McKnight AJ, Powrie F, Dyke R, Mason D. Subsets of CD4+ T cells and their roles in the induction and prevention of autoimmunity. Immunol Rev 1991; 123: 37–64
- Fowell D, Mason D. Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential. J Exp Med 1993; 177: 627–36
- Groen H, Klatter FA, Van Petersen AS, Pater JM, Nieuwen-Huis P, Kampinga J. Composition of rat CD4+ resting memory T cell pool is influenced by MHC. Transplant Proc 1993, in press
- Hess AD, Horwitz L, Beschorner WE, Santos GW. Development of graft-versus-host disease-like syndrome in Cyclo-sporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-la specificity, including autore-activity. J Exp Med 1985; 161: 718–30
- Beschorner WE, Hess AD, Shinn CA, Santos GW. Transfer of Cyclosporine-associated syngeneic graft-versus-host disease by thymocytes. Resemblance to chronic graft-versus-host disease. Transplantation 1988; 45: 209–15
- Glinsky W, Jablonska S. Subsets of systemic sclerosis (SSc) with respect to experimental sensitization of patients to dinitrochlorobenzene (DNCB). Connect Tissue Res 1985; 4: 15–30
- Lupoli S, Amlot P, Black C. Normal immune responses in systemic sclerosis. J Rheumatol 1990; 17: 323–7
- Beschorner WE, Olson JL, Hess AD, Di Gennaro KA, Santos GW. Cyclosporine-induced cell-mediated injury of the thymic medullary epithelium. Transplantation 1988; 45: 797–803
- Beschorner WE, Di Gennaro KA, Hess AD, Santos GW. Cyclosporine and the thymus: Influence of irradiation and age on thymic immunopathology and recovery. Cell Immunol 1987; 110: 350–64
- Kimura H, Wilson DB. Anti-idiotypic cytotoxic T- cells in rats with graft-versus-host disease. Nature 1984; 308: 463–4
- Wilson DB. Idiotypic regulation of T cells in graft-versus-host disease and autoimmunity. Immunol Rev 1989; 107: 159–77